Lambda Biologics retinal organoid provide a reliable model to study retinal development, disease mechanisms, and potential therapies. These systems enable accurate drug screening for disorders such as retinitis pigmentosa and age-related macular degeneration - helping you accelerate discoveries in vision science and treatment development.
Price | 4350€+ |
Organism | Human |
Product Type | iPSC-derived organoid |
Tissue | Retinal |
Disease | – |
Applications
Toxicity
Organoid Based
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Using advanced stem cell differentiation protocols, Lambda Biologics has developed stable and reproducible retinal organoids from human pluripotent stem cells (hPSCs). These models capture the complex architecture of the retina, making them an ideal platform for translational research.
The human retina can be broadlydivided into the Neural Retina and Retinal Pigmented Epithelium. We confirmed the expression of specific markers present in each layer of the retina in theretinal organoids. Around 25 days of cultivation, the presence of Retinal Ganglion Cells and Bipolar Cell layers was observed, along with the expression of the specific marker Paired Box Protein-6 (Pax6). Furthermore, by observing changes in cell arrangement within the organoid andexamining the marker for photosensitive cells (Recoverin), we confirmed thesimilarity of the produced retinal organoid to human tissue.
Interested in bringing human-relevant retinal models into your research?
Contact Lambda Biologics to discuss your project with our team.
A retinal organoid is a 3D tissue model grown from human stem cells that mimics the structure and function of the human retina. It allows researchers to study vision, eye diseases, and new treatments in a human-relevant system.
They are widely used for drug testing, toxicity screening, disease modeling, and vision research. Scientists can study conditions like retinitis pigmentosa or age-related macular degeneration more effectively using these models.
We provide detailed technical data sheets covering differentiation methods, marker expression, and functional validation, so you can trust the reliability and reproducibility of your results.
Retinal organoids are derived from human cells, making them more accurate for predicting how the human eye will respond to drugs or therapies. They reduce reliance on animal testing and provide data that is more relevant for clinical applications.
Simply contact Lambda Biologics team. Our scientists will review your project needs and provide the right options whether it’s technical guidance, a quote, or custom organoid development.
